Welcome to LookChem.com Sign In|Join Free

CAS

  • or

65883-12-7

Post Buying Request

65883-12-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

65883-12-7 Usage

Description

PEG5-Ms is a PEG linker with a mesyl group and a hydroxyl group. The mesyl group is good leaving groups but can also be used as protecting groups for primary alcohols. They can be deprotected in the presence of sodium amalgam. The hydroxyl group can react to further derivatize the compound. The hydrophilic PEG linker increases the water solubility of the compound in aqueous media.

Chemical Properties

Brown Oily Residue

Uses

1-Methanesulfonyl-11-hydroxy-3,6,9-trioxaundecane (cas# 65883-12-7) is a compound useful in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 65883-12-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,8,8 and 3 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 65883-12:
(7*6)+(6*5)+(5*8)+(4*8)+(3*3)+(2*1)+(1*2)=157
157 % 10 = 7
So 65883-12-7 is a valid CAS Registry Number.

65883-12-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl methanesulfonate

1.2 Other means of identification

Product number -
Other names 3,6,9,12-Tetraoxa-2-thiatetradecan-14-ol,2,2-dioxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:65883-12-7 SDS

65883-12-7Relevant articles and documents

Polymer-supported cationic templates for molecular recognition of anionic hosts in water

Besenius, Pol,Cormack, Peter A. G.,Ludlow, R. Frederick,Otto, Sijbren,Sherrington, David C.

, p. 2809 - 2811 (2008)

Translocating solution-phase molecular recognition of oppositely charged hosts and guests to the solid phase represents a major challenge; we report a successful immobilisation strategy which allows selective host-guest interactions in water unencumbered by unwanted ion exchange-type interactions. The Royal Society of Chemistry.

A MedChem toolbox for cereblon-directed PROTACs

Steinebach, Christian,Sosi?, Izidor,Lindner, Stefanie,Bricelj, Ale?a,Kohl, Franziska,Ng, Yuen Lam Dora,Monschke, Marius,Wagner, Karl G.,Kr?nke, Jan,Gütschow, Michael

supporting information, p. 1037 - 1041 (2019/06/27)

A modular chemistry toolbox was developed for cereblon-directed PROTACs. A variety of linkers was attached to a CRBN ligand via the 4-amino position of pomalidomide. We used linkers of different constitution to modulate physicochemical properties. We equipped one terminus of the linker with a set of functional groups, e.g. protected amines, protected carboxylic acids, alkynes, chloroalkanes, and protected alcohols, all of which are considered to be attractive for PROTAC design. We also highlight different opportunities for the expansion of the medicinal chemists' PROTAC toolbox towards heterobifunctional molecules, e.g. with biotin, fluorescent, hydrophobic and peptide tags.

NANOPARTICLES FOR DIAGNOSIS AND DRUG DELIVERY

-

Page/Page column 41; 42, (2017/04/11)

The present invention relatesto a nanoparticle having a size comprised from 2 to 300 nm comprising: (i) a core comprising on its surface a noble metal selected from gold, silver or platinum, and (ii) an optionally positively charged amphiphilic linker comprising a hydrophobic C1-C20 alkyl thiolate moiety and a hydrophilic moietywhich is optionally hydrophilic positively charged. The invention also provides nanovectors comprising the nanoparticles of the invention and a compound of interest,such as a pharmaceutically active agent, in particular an anti-tumoral agent. Also provided are nanoparticles and nanovectors as defined above for diagnosis or for the prevention and/or treatment of a disease, in particular cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 65883-12-7